Search - tctmd.com

Displaying 941 - 960 of 1137

Sort: Relevancy | Date

Presentation EuroPCR 2018

30-day Outcomes of Transcatheter Mitral Valve Replacement in Native Mitral Valve Disease with Severe Mitral Annular Calcification in the United States: Data from the STS/ACC/TVT Registry

Presenter: Mayra Guerrero

May 24, 2018

Presentation EuroPCR 2018

The MitrAl ValvE RepaIr Clinical (MAVERIC) EU/AU trial

Presenter: Simon Redwood

May 24, 2018

News Conference News EuroPCR 2018

Pace Quickens for Mitral Device Innovation for Repair, Replacement

Yael L. Maxwell

May 24, 2018

News Conference News EuroPCR 2018

NOTION: TAVR in Low-Risk Patients Maintains Its Momentum Through 6 Years

Caitlin E. Cox

May 24, 2018

Presentation EuroPCR 2018

GISE Registry of Transcatheter Treatment of Mitral Valve Regurgitation (GIOTTO): Epidemiology and Acute Results

Presenter: Francesco Bedogni

May 23, 2018

News Conference News EuroPCR 2018

Embolic Protection in TAVR: Signs of Benefit, but Road Map for Use Still Uncharted

Caitlin E. Cox

May 23, 2018

Presentation EuroPCR 2018

Anatomical Predictors of Stroke Prevention During Transcatheter Aortic Valve Implantation: The SENTINEL Trial

Presenter: Hasan Jilaihawi

May 23, 2018

News Conference News EuroPCR 2018

EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage

Shelley Wood

May 17, 2018

Podcast TCTMD Talking Points

MITRAL: 30-Day Outcomes of Transcatheter MV Replacement in Severe MV Disease Secondary to Mitral Annular Calcification or Failed Annuloplasty Rings

May 16, 2018

News Daily News

Spin to Win: Results From Late-Breaking Meeting Trials Often Overstated

L.A. McKeown

May 15, 2018

News Featured Fellow

Shivanshu Madan, MD

Yael L. Maxwell

May 14, 2018

News Conference News HRS 2018

Thrombus on the Watchman LAA Occluder Tied to Higher Stroke Risk

Todd Neale

May 14, 2018

Presentation

Causes and Associated Costs of 30-Day Readmission of TAVR vs SAVR in the US

May 11, 2018

News Industry News

Edwards Granted CE Mark For First Transcatheter Tricuspid Therapy

May 01, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for April 2018

Caitlin E. Cox

April 30, 2018

Presentation SCAI 2018

Derivation of a Simple Risk Tool to Predict 30-day Readmissions after Transcatheter Aortic Valve Replacement

Presenter: Sahil Khera

April 28, 2018

Presentation SCAI 2018

Cerebral Embolic Protection: Protect Everyone

Presenter: Samir Kapadia

April 28, 2018

Presentation SCAI 2018

Unresolved Issues: Cerebral Embolic Protection Use Selectively!

Presenter: Steven J Yakubov

April 28, 2018

Presentation SCAI 2018

3D Printing and Computer Modeling to Predict Paravalvular Leak in Transcatheter Aortic Valve Replacement

Presenter: Sergey Gurevich

April 28, 2018

News Conference News SCAI 2018

Debate Over Cerebral Protection in TAVR Fizzles in the Face of Reimbursement Hopes

Shelley Wood

April 28, 2018

Advertisement

30-day Outcomes of Transcatheter Mitral Valve Replacement in Native Mitral Valve Disease with Severe Mitral Annular Calcification in the United States: Data from the STS/ACC/TVT Registry

The MitrAl ValvE RepaIr Clinical (MAVERIC) EU/AU trial

Pace Quickens for Mitral Device Innovation for Repair, Replacement

NOTION: TAVR in Low-Risk Patients Maintains Its Momentum Through 6 Years

GISE Registry of Transcatheter Treatment of Mitral Valve Regurgitation (GIOTTO): Epidemiology and Acute Results

Embolic Protection in TAVR: Signs of Benefit, but Road Map for Use Still Uncharted

Anatomical Predictors of Stroke Prevention During Transcatheter Aortic Valve Implantation: The SENTINEL Trial

EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage

MITRAL: 30-Day Outcomes of Transcatheter MV Replacement in Severe MV Disease Secondary to Mitral Annular Calcification or Failed Annuloplasty Rings

Spin to Win: Results From Late-Breaking Meeting Trials Often Overstated

Shivanshu Madan, MD

Thrombus on the Watchman LAA Occluder Tied to Higher Stroke Risk

Causes and Associated Costs of 30-Day Readmission of TAVR vs SAVR in the US

Edwards Granted CE Mark For First Transcatheter Tricuspid Therapy

TCTMD’s Top 10 Most Popular Stories for April 2018

Derivation of a Simple Risk Tool to Predict 30-day Readmissions after Transcatheter Aortic Valve Replacement

Cerebral Embolic Protection: Protect Everyone

Unresolved Issues: Cerebral Embolic Protection Use Selectively!

3D Printing and Computer Modeling to Predict Paravalvular Leak in Transcatheter Aortic Valve Replacement

Debate Over Cerebral Protection in TAVR Fizzles in the Face of Reimbursement Hopes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content